The Counseling Centers in New Jersey Offer Breakthrough Spravato Treatment to Patients Suffering from Depression Deemed to be "Treatment-Resistant"
The Counseling Center (TCC) is proud to offer Spravato treatment services to patients suffering from Treatment Resistant Depression (TRD) in New Jersey and adjacent areas. Spravato can only be delivered in an accredited healthcare setting like TCC to treat TRD, a persistent form of depression that affects millions of people worldwide. The Counseling Centers' Risk Evaluation and Mitigation Strategy (REMS) certification* ensures the highest standards of safety and quality of care for patients receiving this cutting-edge new treatment.
FREEHOLD, N.J., June 13, 2023 : The Counseling Center (TCC) is proud to offer Spravato treatment services to patients suffering from Treatment Resistant Depression (TRD) in New Jersey and adjacent areas. Spravato can only be delivered in an accredited healthcare setting like TCC to treat TRD, a persistent form of depression that affects millions of people worldwide. The Counseling Centers' Risk Evaluation and Mitigation Strategy (REMS) certification* ensures the highest standards of safety and quality of care for patients receiving this cutting-edge new treatment.
The programs in New Jersey where patients are benefitting from that REMS certification are at The Counseling Center (TCC) a leading provider of comprehensive outpatient services, offering medically supervised programs to help individuals overcome mental health and substance use disorders.
"Spravato has emerged as one of the most promising treatment options for patients with TRD, providing swift relief of symptoms," said Lynda Micheletti, Chief Operating Officer at Praesum Healthcare. " Most importantly, considering the crucial importance of mental health during these times, it offers hope to those who have not responded well to other anti-depressants. We are thrilled to be poised now at The Counseling Centers to deliver exceptional patient care and an innovative new means to improve outcomes for patients who have tried other treatments without symptom relief."
The FDA approved Spravato in 2019, "a nasal spray derived from ketamine," for treating severe depression. It is the singular form of ketamine in the US that is authorized for the treatment of depression. That approval came aligned with strict guardrails and a restricted distribution system allowing only select providers like TCC to distribute Spravato and thus ensure patient safety.
"Our REMS approval for Spravato will enable us to expand our services and reach more patients in need, ensuring the best possible outcomes," added Ms. Micheletti. "At The Counseling Centers we aim to make a positive impact on the fight against TRD and know that our team of trained caregivers will provide accessible and effective treatment options for patients in the local area."
Praesum Healthcare is the parent operator of TCC and, with the full range of treatment services across the Praesum continuum in New Jersey, including inpatient and outpatient treatment programs, detox, mental health services and medication-assisted treatment, its clinical staff often see TRD and welcome its radical new outpatient use.
The opportunity is there to find compassionate, skilled Spravato therapy in New Jersey today. To schedule an appointment for Spravato treatment call 866-850-5001 24/7 or please visit Outpatient Alcohol & Drug Treatment on the East Coast | Mental Health Treatment (thecounselingcenter.com).
The Counseling Center is committed to providing all-encompassing care and guidance to make certain that NJ can take advantage of this potentially life-changing treatment. With Medicare now accepted for SPRAVATO®, additional communities can experience the advantages of this innovative approach to combating depression.
"With the efficacy of Spravato treatment, patients can now receive high-quality care for TRD in multiple New Jersey centers without having to travel a considerable distance," added Mr. Scott Busby, Director of Client Services for Praesum Healthcare/The Counseling Center. "We are committed in New Jersey and beyond to addressing the impact that TRD can have on a person's quality of life, and we are proud to offer a safe and comfortable environment for such an exciting modern treatment."
The Counseling Center offers Spravato treatment at its New Jersey Centers to patients suffering from Treatment Resistant Depression
"I have been at the Counseling Center of Freehold for two years and it has been an enormous help to me. I recently started its Spravato treatment for depression and I could not be happier with how it is going. I have been on 15 other meds in the past and never got the relief I am feeling now. THANK YOU"- Scott S.
Spravato (esketamine) stimulates certain brain neurotransmitters and helps them transmit messages more effectively to govern mood and decrease negative symptoms of depression. It's the first new medication in over twenty years to be FDA-approved for depression with the lifesaving novelty of a different mechanism of action than all other medications on the market.
Outpatient treatment at the The Counseling Center places a high value on family, adolescent, and flexible M.A.T. programs, allowing clients to attend- with minimal interruption to their work and family lives- the day, evening, and weekend sessions. That approach plays well at TCC with the way Spravato can be delivered to the TRD population since it must be established that patients have undergone two or more failed attempts to treat depression.
The means of delivery at TCC may be unexpected to those who expect their antidepressants in an oral or tablet form. Spravato works as a nasal spray fully FDA-approved by way of that delivery system alone.
"I was referred to TCC a month ago by my psychiatrist because its Freehold location offers Spravato treatment. I have been battling major depressive disorder for most of my life with little or no relief using conventional prescription anti-depressants (several different medications over the years with the same result and terrible side effects). Spravato has proven so far to produce profound results in just a short period of time, without all the unpleasant side effects in my case. The staff was friendly and helpful in giving me access to this treatment (covered by my insurance) and provides a flexible schedule (evening hours makes it possible to get Spravato without missing any time at work). If you are struggling with depression that has not responded well to other treatments, I highly recommend you contact these folks for a consultation." Sean K., N.J.
About The Counseling Center/Praesum Health
The Counseling Center is a leading provider of comprehensive outpatient services, with fourteen centers offering medically supervised programs to help individuals overcome mental health and substance use disorders and continue their journey towards recovery. TCC adheres to the highest standards of safety set by REMS and provides unique and secure environments for treatment at our Freehold and Clark, New Jersey locations which serve as REMS-certified treatment centers that specialize in administering Spravato to patients with TRD, withour Toms River location set to launch Spravato treatment imminently.
The fourteen accredited TCC locations throughout New Jersey, New York, Massachusetts, and Georgia offer outpatient treatment for mental health, addiction, alcoholism, and co-occurring mental health disorders associated with substance use. The Center is part of the behavioral health family of Praesum Healthcare, which began in 2004 with a single Sunrise Detox establishment and has expanded to thirty facilities across five states. Praesum has provided services to well over 200,000 patients in various stages of the care continuum. Its team has an established business model, expert management, and twenty years of proven success in the behavioral health industry. Accredited by the Joint Commission and licensed and certified in the five states in which it operates, Praesum provides a strong voice for the recovery community in its treatment leadership.
The FDA requires that health care providers monitor patients for two hours after they take Spravato and REMS is the FDA's Risk & Evaluation and Mitigation Strategy program for select centers administering special drugs. REMS sets standards of safety which must be followed by accredited providers like TCC to ensure the highest standards of care. Almost all possible side effects occur only during and/or a few hours after a session, and so TCC retains a nurse practitioner on-site for all treatments.
